| 
Development in the Seaport District is spilling into the neighboring industrial areas to the east. The 1.4 million-square-foot Innovation and Design Building could get lab space under a proposal from owners Jamestown and Related Beal. Photo courtesy of Jamestown
Lab space conversions within Boston’s Innovation and Design Building received a strong response from tenants that translated into 260,000 square feet in recent leases.
Nine biotechs will bring more than 700 jobs into the Drydock Avenue complex within South Boston’s Raymond L. Flynn Marine Park, landlords Jamestown and Related Beal said.
The firms announced they recently secured leases with the following new tenants:
- Entrada Therapeutics, a biopharmaceutical company for 81,400 square feet
- Shape Therapeutics for 36,500 square feet;
- Jnana Therapeutics for 36,400 square feet;
- Ratio Therapeutics for 19,000 square feet
- Vedere Bio II for 18,900 square feet;
- Seeker Biologics for 18,300 square feet;
- Elektrofi for 18,200 square feet;
- Aktis Oncology for 17,900 square feet;
- Hotspot Therapeutics, which leased 17,300 square feet.
Since buying the IDB in 2013, Jamestown has spent more than $200 million updating the former Boston Army Base structure for a range of companies in the tech, creative, life science and manufacturing sectors. Related Fund Management formed a joint venture with Jamestown in 2022 for the property.
Boston’s Seaport District life science cluster comprises nearly 2.3 million square feet of lab space, and another 1.9 million square feet is under construction, according to recent Newmark research.
